Page 6 - Aduhelm News Today

Retirees will learn the amount of the increase for 2023 in October, and the current estimate is that it will be 8.7%.

WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend...

WASHINGTON (AP) — A closely watched experimental drug for Lou Gehrig’s disease got an...

Analysis Aduhelm is the brand name under which the Alzheimer’s drug Aducanumab is marketed. It is developed by ...

When expensive medicines that protect against getting HIV are available through...

New research hints that even simple exercise just might help seniors with mild memory problems. While physical activity helps keep healthy brains fit, its not clear how much it helps once memory starts to slide.

Value-based pricing could have shown us with more certainty the real level of effectiveness of Aduhelm. Maybe it is worth paying something for; and value-based contracts are the only way to figure that out.

Chronicle readers also react to Sen. Joe Manchin and climate change, S.F.’s slow...

Darlene Bradley always knew Alzheimer’s could be in her future The disease changed her father and is now changing her.

Medicare could potentially waste up to $605 million annually from the packaging of controversial Alzheimer’s drug aducanumab if ...